A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma.Emily K. Slotkin, William D. Tap, Tara J. O’Donohue et al.|Journal of Clinical Oncology|2022Cited by 14
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K. Slotkin, William D. Tap, Audrey Mauguen et al.|JCO oncology advances.|2025Cited by 3